GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GuangYuYuan Chinese Herbal Medicine Co Ltd (SHSE:600771) » Definitions » Capex-to-Revenue

GuangYuYuan Chinese Herbal Medicine Co (SHSE:600771) Capex-to-Revenue : 0.00 (As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is GuangYuYuan Chinese Herbal Medicine Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

GuangYuYuan Chinese Herbal Medicine Co's Capital Expenditure for the three months ended in Mar. 2024 was ¥-0.38 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥343.38 Mil.

Hence, GuangYuYuan Chinese Herbal Medicine Co's Capex-to-Revenue for the three months ended in Mar. 2024 was 0.00.


GuangYuYuan Chinese Herbal Medicine Co Capex-to-Revenue Historical Data

The historical data trend for GuangYuYuan Chinese Herbal Medicine Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GuangYuYuan Chinese Herbal Medicine Co Capex-to-Revenue Chart

GuangYuYuan Chinese Herbal Medicine Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 0.05 0.02 0.01 -

GuangYuYuan Chinese Herbal Medicine Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of GuangYuYuan Chinese Herbal Medicine Co's Capex-to-Revenue

For the Drug Manufacturers - General subindustry, GuangYuYuan Chinese Herbal Medicine Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GuangYuYuan Chinese Herbal Medicine Co's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GuangYuYuan Chinese Herbal Medicine Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where GuangYuYuan Chinese Herbal Medicine Co's Capex-to-Revenue falls into.



GuangYuYuan Chinese Herbal Medicine Co Capex-to-Revenue Calculation

GuangYuYuan Chinese Herbal Medicine Co's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-2.511) / 1284.016
=0.00

GuangYuYuan Chinese Herbal Medicine Co's Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.378) / 343.379
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GuangYuYuan Chinese Herbal Medicine Co  (SHSE:600771) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


GuangYuYuan Chinese Herbal Medicine Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of GuangYuYuan Chinese Herbal Medicine Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


GuangYuYuan Chinese Herbal Medicine Co (SHSE:600771) Business Description

Traded in Other Exchanges
N/A
Address
Gaoxin 6th Road, High-tech Zone, No. 52, Liren Technology Park, Building A, 6th Floor, Xi'an, Shaanxi, CHN
GuangYuYuan Chinese Herbal Medicine Co Ltd distributes pharmaceutical products. Its products include far plate turtle age wine bottle, niuhuang qingxin pills, boutique angong niuhuang wan, modified turtle age wine, ding kundan, and many more.

GuangYuYuan Chinese Herbal Medicine Co (SHSE:600771) Headlines

No Headlines